INTRODUCTION
Central nervous system complications of Mycoplasma pneumoniae infection include various symptoms such as encephalitis, meningitis, myelitis, polyradiculitis, or acute psychosis. These neurologic complications are usually preceded by respiratory symptoms although some patients give no history of the symptoms. The incidence of central nervous system complications among M. pneumoniae infections was reported to be about 0.1 percent. However, the incidence among hospitalized patients was as high as 7 percent [1, 2] .
The overall incidence of current M. pneumoniae infections among patients wth neurological syndromes was 5 percent, with a maximum of 10 percent during the epidemic [3] .
It is suggested that the complications may result from a direct invasion of M. pneumoniae into the brain, a neurotoxin produced by the organism, cross-reacting antibodies to antigen(s) shared by mycoplasma and brain, or from vascular microthrombi with the organism [1] . However, the mechanism of the neurologic disease associated with M. pneumoniae is not fully understood. The present study was undertaken to examine the ability of M. pneumoniae to enter the brain of experimental animals. Adult and suckling mice were challenged with the organism by various routes. In addition, cyclophosphamide-treated mice were infected with M. pneumoniae to examine the susceptibility of compromised hosts to the infection. Young adult mice, 28 days old, and suckling mice, one to seven days old, were infected with the mycoplasma by exposure to the aerosol. Nine ml of the broth culture containing 4 x 10' CFU/ml was nebulized in a desiccator for 50 minutes. As shown in Table 1 , M. pneumoniae was not isolated from any of the lungs of 28-day-old mice under this experimental condition. The susceptibility of one-to four-day-old suckling mice to M. pneumoniae was much higher than that of six-to seven-day and 28-day-old mice, from the numbers of mycoplasmas isolated from lungs. (Table 2) . One-day-old suckling mice were infected with the mycoplasma by exposure to the aerosol. At autopsy 13 days later, the organisms were isolated from the lungs of all animals and from the brains of two of four animals ( Table 2 ). The numbers of organisms isolated from brains were less than the numbers isolated from lungs. M. pneumoniae was not detected in the blood of either the adult or suckling mice at any time of autopsy. The mycoplasma was not isolated from any specimens of the control animals given sterile broth medium throughout these experiments. Table 3 ). The recovery from adult mice which had been inoculated with the same number of mycoplasmas was lower than that from suckling mice. On the other hand, the organism was not isolated from any lung of either the suckling or adult mice. Treatment with Cyclophosphamide Twenty-eight-day-old mice were subjected to treatment with CY to determine if such treatment led to systemic infection. Severe leukopenia was caused by the treatment. In such mice, M. pneumoniae was found not only in the lung but also in brain, spleen, and blood after intravenous infection. Persistence of higher levels of the mycoplasma was noted in those organs during the three-day observation period. On the other hand, in the infected mice which had not been treated with CY, the mycoplasma was not found in the brain at four hours post-infection and disappeared rapidly from the lung, spleen, and blood (Table 4) . DISCUSSION M. pneumoniae has been isolated from cerebrospinal fluid of patients with the meningitis or meningoencephalitis associated with primary atypical pneumonia. This fact suggests that M. pneumoniae can enter the central nervous system. We reported at the Third IOM Congress that M. pneumoniae reached the brain of experimental animals, including adult hamsters and mice. Suckling animals as well as adults were used in the present study.
M. pneumoniae was isolated from lungs and brains of the suckling mice infected by exposure to the aerosol of the organism. The susceptibility of suckling mice to the infection was much higher than that of adults, from the numbers of mycoplasmas isolated from lungs.
To examine the possibility of reaching the brain via blood, mice were inoculated intravenously with the mycoplasma. The systemic spread of infection occurred in the mice treated with high doses of cyclophosphamide. In addition, the high levels of M. pneumoniae persisted for two months or more after the intracerebral inoculation. This fact suggests that the organism can grow in the brain. However, there is no evidence that the organism passes the blood-brain barrier after intravenous or intranasal infection.
Finally, our results suggest that M. pneumoniae may be able to reach the brain via blood and it may occur with relative ease in compromised hosts. However, it seems difficult for the mycoplasma to enter the parenchyma of brain of normal hosts because the isolation rate and titers of the organism from brains were low in intravenously or intranasally infected animals throughout the present experiments. If the injury of blood-brain barrier is produced by a cause such as metabolic disorder, mixed infection, or unknown factor, M. pneumoniae will be able to enter the parenchyma of brain and to grow there.
